Scienture Holdings announced a 256% sequential revenue increase to $1.22 million in Q3 2026, fueled by strong sales of its FDA-approved products Arbli™ and REZENOPY™. The company expanded market access, including formulary additions and strategic partnerships, while maintaining high gross margins near 98%. With established commercial infrastructure and growing product adoption, Scienture aims to continue revenue growth and achieve profitability by 2027.
Scienture's recent shareholder letter highlights its sequential revenue growth and FDA-approved products, providing context for readers. For those following the health sector, here is Pluang's market snapshot as of Oct 22, 2026 19:13 WIB: out of 150 priced US health stocks, 63 rose and 79 fell. Notable movers include AMWL at USD 10.58 with a 1-day change of -24.27% and 100% buy order activity, TWST at USD 142.45 down 4.48% with 93% buy orders, and DGX at USD 229.99 down 3.64%.
Flutter Entertainment, a leading online sports betting and iGaming operator, will release its third quarter 2026 update on November 4 before the US market opens. The company will host a conference call at 8:30 a.m. ET the same day to discuss the resu...
iPower Inc. declared a 1-for-12 reverse stock split effective October 26, 2026, combining every 12 shares into one to increase the stock price. This move aims to keep iPower's shares compliant with Nasdaq's minimum bid price requirements. Post-split,...
U.S. Global Investors has listed its actively managed U.S. Global Technology and Aerospace & Defense ETF (WAR) on Peru's Lima Stock Exchange, marking the first availability of this ETF outside the U.S. This move gives Peruvian investors access to a f...
Alignment Health Plan will launch a new Medicare Advantage plan in Pima County starting January 1, 2027, increasing access to affordable, coordinated healthcare for nearly 1.1 million Medicare beneficiaries across Maricopa, Pima, and Santa Cruz count...
The global Urban Air Mobility (UAM) market is projected to grow from $2.16 billion in 2026 to $16.27 billion by 2035, at a CAGR of 20.9%. This growth is fueled by rising urbanization, traffic congestion, and advances in electric vertical takeoff and ...
